Discussion page for Arch Therapeutics (ARTH)This page is for discussion of Arch Therapeutics (ARTH).
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
I voted against. Says can vote in person on July 1st. Anybody in boston area show up to vote in person and nail them as when they are getting off their asses.
Voted 50,000 shares “against”
$ARTH atlas long
Apparently holders of ARTH shares will be mauled by the dilution relatively soon?
Does anybody have any idea if there’s any possibility for the shares to take one last swing upwards before the dilution or is it game over for us small timers?
It sure has been an exciting ride so far but paying up has to end at some point.
yours, Finn
$ARTH OW Long
If history is any guide, there may be a bit of news that will drive up the SP, to what level I do not know, and then TN will sell a bunch of ARTH stock to cover his salary and his directors for the next year.
Thank you kindly for replying. Let’s hope everyone here are able to get out without damage to portfolio.
Very unfortunate it had to come to this point with ARTH. Such technology but such waste of effort, time, money etc.
When is this massive dilution due?
Just need to reiterate that Paul Manpilly 100x pick this month was :Ideal Power,IPWR.
@pasrby Go away
So, does this mean the IPWR is a false lead?
This is a long thread about ARTH. Anyone coming on here plugging other stuff blatantly like pasrby did. Well yes. It is a false lead. Someone just plugging that particular stock. IPWR is probably worse then ARTH. If it could sell itself he/she wouldn’t be here plugging it.
Hey doc Bonz why don’t you order some ac5 and see if it works. If it does we can start some PR on how great it is. If it doesn’t we can all get out before dilution.
Don’t know what it would cost but I work for a large hospital system. They make all the purchases. Even if it were free, it would have to be approved by the pharmacy committee at the central hospital in Pittsburgh and that is no easy task. Especially for an unknown medication or device. Finally, it looks like they are shooting for the wound care indication for now. Internal surgical use is in the future. Looks like the self assembling peptide gods are saying “NO AC5 FOR YOU” Dr. Bonz!
Hello all,
You know what I think is sad about this procrastination & poor management by Arch Therapeutics, this impending share dilution, this whole frustrating $ARTH thing?
It’s that we, the stoic Gumshoe $ARTH-holding community, will eventually, and maybe soon, give up on Arch Therapeutics and its product that we know should be worth the struggle. We’ll put our remaining funds to a better use, and then our little Gumshoe $ARTH community will disperse and our little time in history will be lost.
Everyone out there! I enjoy your (sporadic) company, and will miss you if you yield to sensible thoughts, pull the plug on $ARTH and disappear into the ether.
(Yes, I know things do change over time, but I’d rather that if we disperse, we disperse after Arch Therapeutics gets a satisfyingly lucrative buyout offer and this product is allowed to do what it needs to do in the world.)
that if we
Cheers,
Penny
Where did “that if we” come from? Ignore it.